Effect of first-line topical medications for the treatment of glaucoma on the ocular surface in a Latin American population
International Ophthalmology · 2026
DOI: 10.1007/s10792-026-04205-5 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Ophthalmology, 2026. Verfasst von Oscar Luis Teherán Forero und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Universidad del Sinú EBZ, Cartagena Sectional, Cartagena, Colombia. oscarteheran@hotmail.com. Hauptthemen laut MEDLINE: Antihypertensive Agents, Glaucoma, Open-Angle, Intraocular Pressure, Cornea. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Sinú.
Abstract (Originalsprache)
Background
First-line drug treatment is the cornerstone of glaucoma management. However, their adverse effects on the ocular surface have led to multiple retrospective studies in previously treated patients. This study evaluated these effects in patients who had never been exposed to these drugs.
Purpose
To evaluate the effect of first-line drugs for the management of primary open-angle glaucoma and ocular hypertension on the cornea over one year of follow-up.
Methods
An observational, longitudinal, and prospective study of patients from the Colombian Caribbean coast with no prior treatment or ocular alterations. The patients were evaluated with the OCT-Cirrus 6000, the Ocular Surface Analyzer (OSA), and the OSDI survey at one-year follow-up. The statistical analysis was performed using the Epi Info v.7.2 software.
Results
A total of 88 eyes of 44 patients with an average age of 62.9 years were analyzed. Total corneal thickness (TCT) decreased from 537.6 to 533.8 µm, with no statistical significance, and total epithelial thickness (TET) decreased from 45.6 to 43.9 µm, a statistically significant difference. The OSDI survey increased from 7.3 to 13.4. The OSA showed a reduction in BUT from 8.3 to 6.9 s, the lipid layer from 3.8 to 3.0 nm, the tear meniscus height from 0.37 to 0.29 mm, and meibomian gland loss increased 12.6% at 1-year follow-up; all of these parameters were statistically significant.
Conclusions
The findings reveal that antiglaucoma medications induce alterations in the ocular surface and cornea, and suggest that the greater the involvement of the corneal epithelium, the greater the symptoms reported by the patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, Universidad del Sinú EBZ, Cartagena Sectional, Cartagena, Colombia. oscarteheran@hotmail.com.
- Universidad del Sinú EBZ, Cartagena Sectional, Cartagena, Colombia. oscarteheran@hotmail.com.
- School of Medicine, Universidad del Sinú EBZ, Cartagena Sectional, Cartagena, Colombia.
- Universidad del Sinú EBZ, Cartagena Sectional, Cartagena, Colombia.
- Faculty of Nursing, Health Services Administration Program, University of Cartagena, Cartagena, Colombia.
Förderung
- University of Sinú
Zitieren
APA
Teherán Forero, O. L., Hoyos Córdoba, L. M., Balmaceda Herrera, C. I., Ortega Buelvas, S., & Ramos Clason, E. (2026). Effect of first-line topical medications for the treatment of glaucoma on the ocular surface in a Latin American population. International Ophthalmology. https://doi.org/10.1007/s10792-026-04205-5
Vancouver
Teherán Forero OL, Hoyos Córdoba LM, Balmaceda Herrera CI, Ortega Buelvas S, Ramos Clason E. Effect of first-line topical medications for the treatment of glaucoma on the ocular surface in a Latin American population. International Ophthalmology. 2026. doi:10.1007/s10792-026-04205-5
BibTeX
@article{TehernForero2026,
author = {Teherán Forero, Oscar Luis and Hoyos Córdoba, Liliana María and Balmaceda Herrera, Cristina Isabel and Ortega Buelvas, Stella and Ramos Clason, Enrique},
title = {Effect of first-line topical medications for the treatment of glaucoma on the ocular surface in a Latin American population},
journal = {International Ophthalmology},
year = {2026},
doi = {10.1007/s10792-026-04205-5}
}
EUVIMED